TransHealthGUIDE: Health help for gender-diverse young adults
Part of Mental health clinical trials.
This study aims to improve healthcare for gender-diverse young adults (ages 18-29) and their caregivers. It involves a program to support transgender and nonbinary health and will take place online.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 29 years old.
- You identify as gender-diverse (for example, transgender, nonbinary, two-spirit, or another gender identity not exclusively male or female).
- You live in one of these states: California, Oregon, Illinois, Maryland, District of Columbia, Vermont, Connecticut, Massachusetts, Michigan, New Jersey, or New York.
- You can speak, read, and write in English.
- You have a device (like a phone, tablet, or computer) with internet access.
- If you are a caregiver of a gender-diverse person aged 18-29, you also qualify.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for teens ages 15 to 21 who identify as transgender or gender-diverse (their gender identity is different from the sex they were assigned at birth). Your participation may help researchers better understand and support transgender and gender-diverse youth.
This study tests a text-message program to help prevent HIV in teens who are transgender, non-binary, or gender-diverse. It aims to see if the program can support healthy choices and reduce risk.
This study looks at people who are preparing to start gender-affirming hormone treatment. It may help researchers understand what support is needed before hormones begin.
This study tests a new online support platform designed for parents of gender-diverse children. It aims to see if parents find it helpful and easy to use, so your participation can help improve support for families like yours.
This trial tests a lifestyle program designed to prevent obesity and eating disorders in transgender and gender-diverse adolescents. It aims to support healthy habits and well-being during a critical developmental stage.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
Hear when a new Transgender Persons trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.